Atrial fibrillation: acute: amiodarone was more effective than digoxin at cardioversion.
|
|
|
Clinical bottom line (level 1b)
-
Patients with recent-onset atrial fibrillation or flutter who received amiodarone compared with digoxin were more likely to revert to sinus rhythm
(NNT =
5
at 24
hours)
.
-
There was no clear difference in the number of adverse effects.
|
|
Hou et al:
European Heart Journal
1995;
16:
521-528
|
Expires
November 2004
|
The study
Unblinded ?concealed randomised
trial
with
intention-to-treat
Setting: acute hospital, Taiwan
50 patients
(aged
range 50 to 82 years; mean 70,
86%
male)
recent-onset atrial fibrillation or flutter (lasting < 10 days and confirmed on ECG or by abrupt-onset symptoms)
Excluded if
cardiogenic shock or hypotension
WPW syndrome with AF or flutter and RR intervals < 270 ms; sick sinus syndrome
paroxysmal AF or flutter previously lasting < 24 hours
consumption of any antiarrhythmic drug
serum K < 3.5 mmol/l
severe hypoxia, metabolic acidosis or thyrotoxicosis
AF following surgery
Control Group: (n = 24, 24 analysed):
digoxin
iv 0.013 mg/kg in three divided doses each over 30 minutes 2 hours apart.
Experimental Group: (n = 26, 26 analysed):
amiodarone
iv 5 mg/min over 1 hour then 3mg/min for 3 hours, then 1 mg/min for 6 hours, then 0.5 mg/min for 14 hours. Patients then started amiodarone 400 mg po for 7 days then 200 mg daily.
100% followed for
24
hours
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| no conversion to sinus rhythm
|
24
hours |
7 (29.2%) |
2 (7.69%) |
74% (-15% to
94%) |
21.5% (0.60% to
42.4%) |
5
(2 to
170)
|
| adverse effects
|
24
hours |
0 (0.00%) |
2 (7.69%) |
% (% to
%) |
-7.69% (-17.9% to
2.55%) |
-13
(NNT = 39 to infinity;
NNH =
6
to infinity)
|
Adverse effects: amiodarone: 1 patient died; another had worsening heart failure.
Comments
- Several studies have failed to show that digoxin has any effect on conversion to sinus rhythm in AF.
Citation
-
Hou
ZY,
Chang
MS,
Chen
CY, et al:
Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone: a randomized, digoxin-controlled study.
European Heart Journal
1995;
16:
521-528
Search Terms:
Contributor: Chris Ball and Clare Wotton,
November 2000
Reviewer:
Clinical Question.
| Patient |
AF or flutter |
| Intervention or Exposure |
amiodarone |
| Comparison |
digoxin |
| Outcome |
sinus rhythm |
|
|